E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/10/2006 in the Prospect News Biotech Daily.

Jefferies puts SFBC at buy

SFBC International, Inc. was given a buy rating by Jefferies & Co., Inc. analyst David Windley. The company reported GAAP earnings per share of ($0.23), with non-GAAP of $0.13. Jefferies estimated non-GAAP earnings per share of $0.30. SFBC had total revenue for the first quarter of $80.1 million, higher than the analyst's estimate of $78.9 million. Management lowered its 2006 guidance to $0.73-$0.85 (non-GAAP), from $1.44-$1.58. Shares of the Princeton, N.J., drug development services company were down $6.43 or 27.07%, at $17.32 on volume of 6,179,559 shares versus the three-month running average of 906,700 shares. (Nasdaq: SFCC)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.